Intestinal alkaline phosphatase contributes to the reduction of severe intestinal epithelial damage.

[1]  R. Xavier,et al.  Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43 , 2009, Nature.

[2]  G. Dijkstra,et al.  Role of alkaline phosphatase in colitis in man and rats , 2008, Gut.

[3]  D. Philpott,et al.  A new role for intestinal alkaline phosphatase in gut barrier maintenance. , 2008, Gastroenterology.

[4]  Kyle R. Eberlin,et al.  Intestinal alkaline phosphatase is a gut mucosal defense factor maintained by enteral nutrition , 2008, Proceedings of the National Academy of Sciences.

[5]  D. Hackam,et al.  The role of epithelial Toll‐like receptor signaling in the pathogenesis of intestinal inflammation , 2008, Journal of leukocyte biology.

[6]  Jennifer M. Bates,et al.  Intestinal alkaline phosphatase detoxifies lipopolysaccharide and prevents inflammation in zebrafish in response to the gut microbiota. , 2007, Cell host & microbe.

[7]  W. Walker,et al.  Butyrate Regulates the Expression of Pathogen-Triggered IL-8 in Intestinal Epithelia , 2007, Pediatric Research.

[8]  S. Tedelind,et al.  Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease. , 2007, World journal of gastroenterology.

[9]  Jongdae Lee,et al.  Toll-like receptor signaling in intestinal epithelial cells contributes to colonic homoeostasis , 2007, Current opinion in gastroenterology.

[10]  R. Hodin,et al.  The Pro-inflammatory Cytokines, IL-1β and TNF-α, Inhibit Intestinal Alkaline Phosphatase Gene Expression , 2006 .

[11]  R. Xu,et al.  Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine. , 2006, Gastroenterology.

[12]  Sang Kil Lee,et al.  Cellular differentiation-induced attenuation of LPS response in HT-29 cells is related to the down-regulation of TLR4 expression. , 2005, Biochemical and biophysical research communications.

[13]  G. Corazza,et al.  Oral butyrate for mildly to moderately active Crohn's disease , 2005, Alimentary pharmacology & therapeutics.

[14]  C. Pothoulakis,et al.  Pathophysiological role of Toll-like receptor 5 engagement by bacterial flagellin in colonic inflammation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Simon C Watkins,et al.  Increased expression and function of integrins in enterocytes by endotoxin impairs epithelial restitution. , 2005, Gastroenterology.

[16]  A. Zarzuelo,et al.  Induction of alkaline phosphatase in the inflamed intestine: a novel pharmacological target for inflammatory bowel disease. , 2004, Biochemical pharmacology.

[17]  D. Meijer,et al.  PROTECTION AGAINST AN ESCHERICHIA COLI-INDUCED SEPSIS BY ALKALINE PHOSPHATASE IN MICE , 2004, Shock.

[18]  T. Matsunaga,et al.  Ambroxol reduces LPS toxicity mediated by induction of alkaline phosphatases in rat lung. , 2004, Clinical biochemistry.

[19]  Ruslan Medzhitov,et al.  Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis , 2004, Cell.

[20]  R Balfour Sartor,et al.  Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. , 2004, Gastroenterology.

[21]  W. Seinen,et al.  Calf Intestinal Alkaline Phosphatase, a Novel Therapeutic Drug for Lipopolysaccharide (LPS)-Mediated Diseases, Attenuates LPS Toxicity in Mice and Piglets , 2003, Journal of Pharmacology and Experimental Therapeutics.

[22]  M. Hornef,et al.  Intracellular Recognition of Lipopolysaccharide by Toll-like Receptor 4 in Intestinal Epithelial Cells , 2003, The Journal of experimental medicine.

[23]  D. Meijer,et al.  Removal of Phosphate from Lipid A as a Strategy to Detoxify Lipopolysaccharide , 2002, Shock.

[24]  T. Matsunaga,et al.  Alkaline phosphatases reduce toxicity of lipopolysaccharides in vivo and in vitro through dephosphorylation. , 2002, Clinical Biochemistry.

[25]  J. Schölmerich,et al.  Different Subsets of Enteric Bacteria Induce and Perpetuate Experimental Colitis in Rats and Mice , 2001, Infection and Immunity.

[26]  I. Sasaki,et al.  Sodium Butyrate-Induced Liver-Type Alkaline Phosphatase Activity in a Small Intestinal Epithelial Cell Line, IEC6 , 1998, Digestive Diseases and Sciences.

[27]  D. Meijer,et al.  Dephosphorylation of endotoxin by alkaline phosphatase in vivo. , 1997, The American journal of pathology.

[28]  D. Meijer,et al.  A physiologic function for alkaline phosphatase: endotoxin detoxification. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[29]  J. Baker,et al.  Treatment of left‐sided ulcerative colitis with butyrate enemas: a controlled trial , 1996, Alimentary pharmacology & therapeutics.

[30]  S. Kernéis,et al.  Transimmortalized mouse intestinal cells (m-ICc12) that maintain a crypt phenotype. , 1996, The American journal of physiology.

[31]  J. Cohen,et al.  The relationship between faecal endotoxin and faecal microflora of the C57BL mouse , 1985, Journal of Hygiene.

[32]  J. Wiggins,et al.  Influence of fine structure of lipid A on Limulus amebocyte lysate clotting and toxic activities , 1984, Infection and immunity.

[33]  J. Turnay,et al.  Differentiation of human colon adenocarcinoma cells alters the expression and intracellular localization of annexins A1, A2, and A5 , 2005, Journal of cellular biochemistry.